Doctors Note Logo

Published on: 10/1/2026

When to get Tdap in pregnancy, and why the timing matters

Tdap is recommended during every pregnancy, ideally between 27 and 36 weeks, with the earlier part of that window preferred because it gives your body time to make protective antibodies and pass the highest amount to your baby before birth. That transfer matters because newborns cannot receive their own whooping cough vaccine until 2 months of age, leaving a dangerous gap when pertussis is most likely to be severe or fatal. Timing can shift in certain situations, including wound management, local outbreaks, risk of preterm delivery, or if the shot was missed entirely, so see below for the full details on each scenario before assuming one date fits all.

If you are pregnant and noticing a lingering cough, fever, breathing changes, or other symptoms you cannot explain, guessing wastes time you may not have, and both your health and your baby's can depend on acting quickly. Take a free, instant, online symptom check to better understand what may be going on and what step to take next.

Last reviewed for medical accuracy: 10/01/2026

answer background

Explanation

When to Get Tdap in Pregnancy, and Why the Timing Matters

Getting the Tdap vaccine during pregnancy is one of the most effective ways to protect your newborn from pertussis (whooping cough). Pertussis can be life-threatening for infants too young to be fully vaccinated, and maternal vaccination helps shield your baby until they can build their own immunity.

Below, you’ll find clear guidance on when to get Tdap in pregnancy, why the exact timing matters, and what to discuss with your healthcare provider.


Why Tdap Matters in Pregnancy

  • Pertussis risk to infants
    Newborns can’t start their own pertussis shots until about 2 months of age. In the meantime, they rely on antibodies passed from mom.
  • Passive immunity
    When you get Tdap, your body makes protective antibodies that cross the placenta and circulate in your baby’s bloodstream.
  • Repeat vaccination each pregnancy
    Antibody levels wane over time. Getting Tdap during each pregnancy ensures optimal protection for every baby.

Credible guidelines from the Centers for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists (ACOG) form the basis of these recommendations.


When to Get Tdap in Pregnancy

Experts agree on the best window for vaccination:

  • Aim for between 27 and 36 weeks’ gestation, with the ideal period at 27–32 weeks.
  • If you receive Tdap earlier or later, you may still gain some protection—better late than never—but peak antibody transfer occurs in that 27–32-week window.

Why this window?

  • Maximized antibody transfer
    Antibody levels in your blood are highest about two weeks after vaccination. Administering Tdap during 27–32 weeks ensures your baby has strong levels at birth.
  • Flexibility in scheduling
    If you have a preterm delivery (before 37 weeks), earlier vaccination within this window still offers protection.

How Timing Impacts Your Baby’s Protection

  1. Optimal antibody levels
    Vaccinating too early (before 27 weeks) means your antibodies may peak and wane before delivery.
  2. Preterm babies benefit most
    Earlier in-pregnancy vaccination within the recommended window still helps if you deliver early.
  3. Avoid rushing too late
    Waiting until after 36 weeks may not allow enough time for peak antibody production and transfer.

In short, the “sweet spot” of 27–32 weeks gestation gives you the best chance to build and share strong immunity with your baby.


Safety of Tdap During Pregnancy

  • Decades of data indicate Tdap is safe for both pregnant people and their babies.
  • Common side effects are mild and may include:
    • Soreness, redness or swelling at injection site
    • Low-grade fever
    • Mild headache or fatigue
  • No increased risk of miscarriage, preterm birth, or birth defects has been linked to Tdap.

Your provider will review your medical history and discuss any concerns before giving the vaccine.


What If You Miss the Recommended Window?

  • After 36 weeks: You may still receive Tdap, though the antibody transfer might be slightly less.
  • Postpartum vaccination: If no Tdap during pregnancy, get vaccinated right after delivery to protect yourself and reduce the risk of passing pertussis to your newborn.
  • Close contacts (“cocooning”): Encourage partners, siblings, grandparents, and caregivers to have up-to-date Tdap to surround baby with protection.

Talking to Your Healthcare Provider

Every pregnancy is unique. When you visit your OB-GYN, midwife, or family doctor, bring up:

  • Your gestational age and due date
  • Any previous Tdap history or reactions
  • Concerns about side effects or needle phobia
  • Questions about other vaccines (like influenza) in pregnancy

If you experience worrisome symptoms—any serious pain, high fever, or signs of an allergic reaction—you should speak to your doctor right away. For initial guidance on common symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.


Key Takeaways

  • When to get Tdap in pregnancy: Ideally between 27 and 32 weeks, but anytime from 27–36 weeks is acceptable.
  • Why timing matters: Ensures peak antibody levels transfer to baby, offering early protection.
  • Safety profile: Strong evidence supports Tdap safety in pregnancy; side effects are generally mild.
  • Missed window: Vaccinate postpartum and encourage family and caregivers to stay up to date.

By planning ahead and discussing timing with your provider, you’ll give your newborn the best start against pertussis.


Important: This information is not a substitute for professional medical advice. Always discuss any serious or life-threatening concerns directly with your doctor.

(References)

  • * Bonacorsi S, Farnoux C, Bidet P, Caro V, Aizenfisz S, Benhayoun M, Aujard Y, Guiso N, Bingen E. Treatment failure of nosocomial pertussis infection in a very-low-birth-weight neonate. J Clin Microbiol. 2006 Oct;44(10):3830-2. doi: 10.1128/JCM.01062-06. PMID: 17021121; PMCID: PMC1594806.

  • * Campos-Outcalt D. Vaccine update: the latest from ACIP. J Fam Pract. 2013 Mar;62(3):137-44. PMID: 23520584.

  • * Locht C. Pertussis: acellular, whole-cell, new vaccines, what to choose? Expert Rev Vaccines. 2016 Jun;15(6):671-3. doi: 10.1586/14760584.2016.1161511. Epub 2016 Mar 21. PMID: 26938372.

  • * Smith A, Barr WB, Bassett-Novoa E, LeFevre N. Maternity Care Update: Prenatal Care and Specific Conditions. FP Essent. 2018 Apr;467:17-24. PMID: 29683306.

  • * Barug D, Pronk I, van Houten MA, Versteegh FGA, Knol MJ, van de Kassteele J, Berbers GAM, Sanders EAM, Rots NY. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial. Lancet Infect Dis. 2019 Apr;19(4):392-401. doi: 10.1016/S1473-3099(18)30717-5. Epub 2019 Mar 27. PMID: 30938299.

  • * Jina A, Wang TL, Seyferth ER, Cohen A, Bernstein HH. Increasing antepartum Tdap vaccine administration: A quality improvement initiative. Vaccine. 2019 Jun 19;37(28):3654-3659. doi: 10.1016/j.vaccine.2019.05.045. Epub 2019 May 20. PMID: 31122862.

  • * Heavey E. Guiding patients to appropriate vaccination during pregnancy. Nurse Pract. 2020 Jun;45(6):19-24. doi: 10.1097/01.NPR.0000666180.07149.f6. PMID: 32345831.

  • * Guzman-Holst A, Luna-Casas G, Cervantes-Apolinar MY, Huerta-Garcia GC, Juliao P, Sánchez-González G. Pertussis infant morbidity and mortality trends after universal maternal immunisation in Mexico: An ecological database study with time-series analysis. Vaccine. 2021 Apr 15;39(16):2311-2318. doi: 10.1016/j.vaccine.2021.02.038. Epub 2021 Mar 25. PMID: 33773845.

  • * Bernstein HH, Tong-Miller S, Cleary SS, Sherin M, Spino C. Factors Influencing Maternal Antepartum Tdap Vaccination. Matern Child Health J. 2022 Dec;26(12):2385-2395. doi: 10.1007/s10995-022-03557-5. Epub 2022 Sep 29. PMID: 36173502; PMCID: PMC9519405.

  • * Mohammed H, Andraweera P, Marshall HS. A cohort study to assess the safety and coverage of COVID-19, influenza, and pertussis vaccine in Australian pregnant women. Vaccine. 2026 Oct 3;91:129081. doi: 10.1016/j.vaccine.2026.129081. Epub 2026 Aug 29. PMID: 42667899.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.